Ingrid Dijkgraaf Selected Research

Ingrid Dijkgraaf Research Topics

Disease

19	Neoplasms (Cancer) 06/2021 - 11/2002
7	Inflammation (Inflammations) 01/2021 - 11/2011
4	Thrombosis (Thrombus) 01/2022 - 01/2021
4	Atherosclerosis 01/2021 - 01/2017
4	Neoplasm Metastasis (Metastasis) 10/2019 - 11/2006
2	Myocardial Infarction 01/2015 - 12/2014
2	Carcinoma (Carcinomatosis) 02/2007 - 08/2004
1	Pathologic Constriction (Stenosis) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Dermatitis 10/2019
1	Melanoma (Melanoma, Malignant) 10/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Acute Lung Injury 01/2017
1	Ischemia 10/2016
1	Infarction (Infarctions) 01/2015
1	Fibrosis (Cirrhosis) 12/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2012
1	Infections 11/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2007

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 06/2021 - 11/2002
7	IntegrinsIBA 03/2021 - 08/2004
7	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2019 - 11/2002
7	arginyl-glycyl-aspartic acidIBA 10/2019 - 11/2002
6	Integrin beta3 (GPIIIa)IBA 12/2009 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2006
5	ChemokinesIBA 10/2020 - 01/2017
5	cyclic arginine-glycine-aspartic acid peptideIBA 10/2019 - 11/2006
5	Biological ProductsIBA 01/2019 - 03/2007
4	Radioisotopes (Radionuclides)IBA 05/2010 - 08/2004
3	LigandsIBA 10/2020 - 12/2009
3	Integrin alphaVbeta3IBA 01/2009 - 11/2002
3	aspartic acid glycine arginineIBA 01/2007 - 08/2004
2	FibrinIBA 01/2022 - 01/2021
2	AnticoagulantsIBA 03/2021 - 01/2021
2	3-Tyr-octreotideIBA 06/2012 - 05/2010
2	Chemokine ReceptorsIBA 11/2011 - 11/2011
2	Extracellular Matrix ProteinsIBA 01/2009 - 11/2006
2	Peptide Receptors (Peptide Receptor)IBA 02/2007 - 08/2004
1	Epidermal Growth Factor (EGF)IBA 06/2021
1	penetratinIBA 06/2021
1	nonaarginineIBA 06/2021
1	Vitamin K FDA Link 01/2021
1	Eptifibatide (Integrilin)FDA Link 01/2021
1	Dabigatran FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	disagreginIBA 01/2021
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	CC ChemokinesIBA 10/2020
1	Galectins (Galectin)IBA 01/2020
1	sharpinIBA 10/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Salivary Proteins and PeptidesIBA 01/2019
1	Chemokine CXCL1IBA 10/2016
1	matrigelIBA 01/2015
1	IsotopesIBA 01/2015
1	salicylhydroxamic acid (SHAM)IBA 12/2014
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2013
1	Leucine EnkephalinIBA 06/2012
1	Bombesin Receptors (Bombesin Receptor)IBA 06/2012
1	BombesinIBA 06/2012
1	plerixafor FDA Link 11/2011
1	Blood Proteins (Serum Proteins)IBA 11/2011
1	Oxygen (Dioxygen)IBA 12/2009
1	Fibronectins (Fibronectin)IBA 12/2009
1	AntigensIBA 12/2009
1	TenascinIBA 12/2009
1	AntibodiesIBA 12/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Arginine (L-Arginine)FDA Link 01/2009
1	Aspartic Acid (Aspartate)FDA Link 01/2009
1	RadiopharmaceuticalsIBA 09/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2007
1	Dendrimers (Dendrons)IBA 03/2007
1	Lysine (L-Lysine)FDA Link 01/2007
1	Glutamic Acid (Glutamate)FDA Link 01/2007
1	VitronectinIBA 11/2006
1	PeptoidsIBA 11/2006
1	PeptidomimeticsIBA 11/2006
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 11/2002
1	7- (2- bis(2- hydroxyethyl)aminoethyl)theophylline (G 111)IBA 11/2002

Therapy/Procedure

5	Therapeutics 06/2013 - 08/2004
2	Ligation 01/2022 - 01/2015